PATENT CLAIM ANALYSIS

Application Number: 15925559
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "210190"]

Abstract:
The present invention relates to inhibitors of histone deacetylases, in particular HDAC8, that are useful for the treatment of cancer and other diseases and disorders, as well as the synthesis and applications of said inhibitors.

Claim (Index 46):
The compound of  claim 45 , wherein R c  is aryl, optionally substituted with one or more R d .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15067605', '15255817', '11969975', '12734030', '15711794']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.772134186827635
- 35 USC 102 Novelty (BERT): 0.5561403807093289
- Combined Prediction Score: 0.7505348062158045
- Mean Citation Score: 337.928422
- Max Citation Score: 444.2229
- Similarity Product: 261.2673529606998

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test